Michael Sepulveda, MD
Internal Medicine · San Juan Bautista, CANPI 1164425757
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Boehringer Ingelheim at 25.0% of the total. 2025 is the largest year on record at $1,045, 5.3 times the $196 reported in 2019.
Across 201 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$863
- Novo Nordisk$830
- Merck$432
- Amgen$282
- GSK$192
- AbbVie$169
- plus $686 from 15 others
Across 5 payments — averaging $2137.05 each. An ownership or investment interest held by the physician or an immediate family member.
- Brainscope Company, Inc.$11K
What the payments were for
- Food & beverage$3,455100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 44 | $863 |
| Novo Nordisk | 52 | $830 |
| Merck | 28 | $432 |
| Amgen | 22 | $282 |
| GSK | 10 | $192 |
| AbbVie(2 entities) | 8 | $169 |
| AstraZeneca | 9 | $136 |
| Pfizer | 5 | $127 |
| Bayer | 4 | $78 |
| Seqirus USA Inc | 2 | $58 |
| Medtronic | 3 | $52 |
| Coopersurgical, Inc. | 1 | $45 |
| Hologic Sales And Service, LLC | 2 | $28 |
| Viiv Healthcare Company | 1 | $25 |
| Organon | 3 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Dynavax Technologies Corporation | 2 | $20 |
| Exact Sciences | 1 | $19 |
| Vertex | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Genentech USA, Inc. | 1 | $13 |
How this compares
$3,455 in reported general payments places this provider in the 85th percentile of 13,581 internal medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Morphine Sulfate ErMorphine Sulfate | 11 | $902 |
| Atorvastatin Calcium | 27 | $374 |
| Oxycodone Hcl | 11 | $356 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $124 |
| Losartan Potassium | 18 | $109 |
| Amlodipine Besylate | 14 | $85 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in San Juan Bautista
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Hatim HusainSan Diego$2M
- Teck LingPalo Alto$1.1M
- Hyong Kimla Jolla$1M
- Rohit Loombala Jolla$965K
- Fred CohenSan Francisco$929K
- Steven EdelmanSan Diego$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.